Reality is beginning to sink in. Despite the availability of a growing number of COVID-19 vaccines and other therapies, the SARS-CoV-2 virus is likely to become endemic in the medium term, if not longer. A handful of coronaviruses — among them strains of NL63, OC43, 229E and HKU1 — are already endemic. For drug developers,…